Showing 19,881 - 19,900 results of 106,149 for search '(( 50 ((((mean decrease) OR (nn decrease))) OR (a decrease)) ) OR ( a we decrease ))', query time: 1.45s Refine Results
  1. 19881

    List of bacterial strains and plasmids used. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  2. 19882

    <i>E</i>. <i>coli</i> gene knockout mutans resistant to zinc. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  3. 19883

    Primers used in this study. by Riko Shirakawa (13040376)

    Published 2023
    “…We found that knockout mutant of RpmJ (L36), a 50S ribosomal protein, exhibited zinc resistance. …”
  4. 19884

    Effects of Telestroke on Thrombolysis Times and Outcomes: A Meta-analysis by Alireza Baratloo (4778247)

    Published 2018
    “…Although the overall effect estimate (under the fixed-effect model) showed a significant decrease in the onset-to-treatment (OTT) duration in the telestroke group (MD = −5.83 minutes, 95% CI [−8.57, −3.09]), employing the random-effects model for between-study heterogeneity abolished this significance (MD = −5.90 minutes, 95% CI [−13.23, 1.42]). …”
  5. 19885

    Light Increases Energy Transfer Efficiency in a Boreal Stream by Jūratė Lesutienė (664026)

    Published 2014
    “…Also, high heterotrophic microbial activity under low light levels would facilitate energy loss through respiration and decrease overall trophic transfer efficiency. These findings suggest that even a small increase in light intensity could result in community-wide effects on periphyton in boreal streams, with a subsequent increase in energy transfer and system productivity.…”
  6. 19886

    Image_5_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.tif by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  7. 19887
  8. 19888
  9. 19889

    Table_3_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.xlsx by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  10. 19890

    Table_5_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.xlsx by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  11. 19891

    Table_1_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.xlsx by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  12. 19892

    Image_2_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.tif by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  13. 19893

    Table_2_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.xlsx by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  14. 19894

    Table_1_Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation.xlsx by María Noel Spangenberg (16976862)

    Published 2023
    “…</p>Case presentation<p>We present the case of a family with two brothers who presented with mycosis fungoides as an exclusive symptom of a common variable immunodeficiency disorder (CVID). …”
  15. 19895

    Image_3_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.tif by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  16. 19896

    Table_4_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.xlsx by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  17. 19897

    Table_2_Case Report: Mycosis fungoides as an exclusive manifestation of common variable immunodeficiency in a family with a NFKB2 gene mutation.xlsx by María Noel Spangenberg (16976862)

    Published 2023
    “…</p>Case presentation<p>We present the case of a family with two brothers who presented with mycosis fungoides as an exclusive symptom of a common variable immunodeficiency disorder (CVID). …”
  18. 19898

    Image_4_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.tif by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  19. 19899

    Image_1_Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.tif by Zesheng Peng (14792245)

    Published 2023
    “…<p>Malignant glioma is the most frequent primary tumor of the central nervous system. PDCL3 is a member of the phosducin-like protein family, and its imbalance has been shown to be associated with several human diseases. …”
  20. 19900

    Critical role of miR-10b in B-Raf<sup>V600E</sup> dependent anchorage independent growth and invasion of melanoma cells by Ila Datar (433874)

    Published 2019
    “…<div><p>Recent high-throughput-sequencing of cancer genomes has identified oncogenic mutations in the <i>B-Raf</i> genetic locus as one of the critical events in melanomagenesis. <i>B-Raf</i> encodes a serine/threonine kinase that regulates the MAPK/ERK kinase (MEK) and extracellular signal-regulated kinase (ERK) protein kinase cascade. …”